Latest Sanofi Stories
SAN DIEGO, Jan. 21, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the appointment of Jean-Pierre Bizzari, M.D. to its Board of Directors. Dr.
TARRYTOWN, N.Y. and PARIS, Jan.
Primary efficacy endpoints met in two trials of alirocumab administered every four weeks TARRYTOWN, N.Y. and PARIS, Jan. 9, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
The increased adoption of insulin pens and growing number of diagnosed diabetics will drive the US market for modern insulin to over $17 billion by 2020, reports iData Research. Vancouver,
Seven-fold lower incidence of VTE in patients treated with ISIS-FXI Rx compared with enoxaparin CARLSBAD, Calif., Dec. 7, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
NEW YORK, Dec. 4, 2014 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Sanofi.
ReportsnReports.com adds Hepatitis B Global Clinical Trials Review H2 2014 to its store.
Company Appoints Director of IT Services, Continues to Chart Record Growth and Momentum in Technology Sector ATLANTA, Dec.